Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome

NCT04625556 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT04625556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04625556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome
Lead sponsor
Yonsei University
Phase
Observational
Overall status
Recruiting
Start date
December 19, 2022
Completion date
October 31, 2030
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, prostate cancer, renal cell cancer, ureter cancer, urological malignancies